Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China · Delayed Price · Currency is CNY 10.31
+0.08 (0.78%)
At close: Feb 3, 2026
SHA:600267 Market Cap
SHA:600267 has a market cap or net worth of 11.99 billion as of February 3, 2026. Its market cap has increased by 21.87% in one year.
Market Cap
11.99B
Enterprise Value
14.13B
Revenue
9.84B
Ranking
n/a
PE Ratio
21.72
Stock Price
10.31
Market Cap Chart
Since August 15, 2006, SHA:600267's market cap has increased from 2.44B to 11.99B, an increase of 392.46%. That is a compound annual growth rate of 8.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 11.90B | 3.44% |
| Dec 31, 2025 | 11.50B | 18.59% |
| Dec 31, 2024 | 9.70B | -12.87% |
| Dec 29, 2023 | 11.13B | -13.94% |
| Dec 30, 2022 | 12.94B | -22.69% |
| Dec 31, 2021 | 16.73B | 4.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tibet Rhodiola Pharmaceutical Holding Co. | 13.36B |
| Guangdong Taienkang Pharmaceutical | 13.34B |
| Porton Pharma Solutions | 13.20B |
| Shenzhen Chipscreen Biosciences | 12.47B |
| Beijing Foyou Pharma CO.,LTD | 12.18B |
| Henan Lingrui Pharmaceutical | 12.13B |
| Mayinglong Pharmaceutical Group | 11.72B |
| Zhejiang CONBA Pharmaceutical | 11.36B |